Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00411723
Status:
UNKNOWN
Last Update Posted:
2009-02-20
First Post:
2006-12-12
Brief Title:
Safety Study of RTL1000 Recombinant T Cell Receptor Ligand in Subjects With Multiple Sclerosis
Sponsor:
Artielle ImmunoTherapeutics
Organization:
Artielle ImmunoTherapeutics
Organization Data
Organization:
Artielle ImmunoTherapeutics
Class:
INDUSTRY
Study ID:
RTL1000-10001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Artielle ImmunoTherapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Andrew S Goldstein
Old Organization:
Artielle ImmunoTherapeutics Inc